Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis

Current Opinion in Immunology

Volumn 25, Issue 6, 2013, Pages 728-735

  Holers, V Michael ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRULLINATED PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

AUTOIMMUNITY; CELLULAR IMMUNITY; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; HUMAN; HUMORAL IMMUNITY; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; BIOLOGICAL MARKERS; HUMANS; MUCOUS MEMBRANE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RISK FACTORS;

EID: 84889088138     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.09.018     Document Type: Review

References (86)

1. Lee D.M., Weinblatt M.E. Rheumatoid arthritis. Lancet 2001, 359:903-911.
2. Silman A.J. Epidemiology of rheumatoid arthritis. APMIS 1994, 102:721-728.
3. Fuchs H.A., Sergent J.S. Rheumatoid arthritis: the clinical picture. Arthritis and Allied Conditions: A Textbook of Rheumatology 1997, 1041-1070. Williams and Wilkins. edn 13. W.J. Koopman, M.D. Baltimore (Eds.).
4. Klareskog L., Malmstrom V., Lundberg K., Padyukov L., Alfredsson L. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin Immunol 2011, 23:92-98.
5. Padyukov L., Silva C., Stolt P., Alfredsson L., Klareskog L. A gene-environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis. Arthritis Rheum 2004, 50:3085-3092.
6. Klareskog L., Ronnelid J., Lundberg K., Padyukov L., Alfredsson L. Immunity to citrullinated proteins in rheumatoid arthritis. Annu Rev Immunol 2008, 26:651-675.
7. Nepom G.T., Nepom B.S. Prediction of susceptibility to rheumatoid arthritis by human leukocyte antigen phenotyping. Rheum Dis Clin North Am 1992, 18:785-792.
8. Begovich A.B., Carlton V.E., Honigberg L.A., Schrodi S.J., Chokkalingam A.P., Alexander H.C., Ardlie K.G., Huang Q., Smith A.M., Spoerke J.M., Conn M.T., Chang M., Saiki R.K., Catanese J.J., Leong D.U., Garcia V.E., McAllister L.B., Jeffery D.A., Lee A.T., Batliwalla F.M., Remmers E., Criswell L.A., Seldin M.F., Kastner D.L., Amos C.I., Sninsky J.J., Gregersen P.K. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Human Genet 2004, 75:330-337.
9. Bax M., van Heemst J., Huizinga T.W.J., Toes R.E.M. Genetics of rheumatoid arthritis: what have we learned?. Immunogenetics 2011, 63:459-466.
10. Karlson E.W., Deane K.D. Environmental and gene-environment interactions and risk of rheumatoid arthritis. Rheum Dis Clin North Am 2012, 38:405-426.
11. Klareskog L., Stolt P., Lundberg K., Kallberg H., Bengtsson C., Grunewald J., Ronnelid J., Harris H.E., Ulfgren A.K., Rantapaa Dahlqvist S., Eklund A., Padyukov L., Alfredsson L. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006, 54:38-46.
12. Prince F.H., Bykerk V.P., Shadick N.A., Iannaccone C.K., Weinblatt M.E., Solomon D.H. Sustained rheumatoid arthritis remission is uncommon in clinical practice. Arthritis Care Res 2012, 14:R68. 10.1186/ar3785.
13. Schrohenloher R.E., Bridget S.L., Koopman W.J. Rheumatoid factor. Arthritis and Allied Conditions: A Textbook of Rheumatology 1997, 1109-1130. Williams and Wilkins. edn 13. W.J. Koopman, M.D. Baltimore (Eds.).
14. Newkirk M.M. Rheumatoid factors: what do they tell us?. J Rheumatol 2000, 29:2034-2040.
15. Girbal-Neuhauser E., Durieux J.J., Arnaud M., Dalbon P., Sebbag M., Vincent C., Simon M., Senshu T., Masson-Bessiere C., Jolivet-Reynaud C., Jolivet M., Serre G. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999, 162:585-594.
16. Schellekens G.A., de Jong B.A.W., van den Hoogen F.H.J., van de Putte L.B.A., van Venrooij W.J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998, 101:273-281.
17. Schellekens G.A., Visser H., de Jong B.A.W., van den Hoogen F.H.J., Hazes J.M.W., Breedveld F.C., van Venrooij W.J. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000, 43:155-163.
18. Bicker K.L., Thompson P.R. The protein arginine deiminases: structure, function, inhibition, and disease. Biopolymers 2013, 99:155-163.
19. Darrah E., Rosen A., Giles J.T., Andrade F. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis. Ann Rheum Dis 2012, 71:92-98.
20. Andrade F., Darrah E., Gucek M., Cole R.N., Rosen A., Zhu X. Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. Arthritis Rheum 2010, 62:1630-1640.
21. Hueber W., Kidd B.A., Tomooka B.H., Lee B.J., Bruce B., Fries J.F., Sonderstrup G., Monach P., Drijfhout J.W., vanVenrooij W.J., Utz P.J., Genovese M.C., Robinson W.H. Antigen microarray profiling of autoantibodies in rheumatoid arthritis. Arthritis Rheum 2005, 52:2645-2655.
22. Lundberg K., Bengtsson C., Kharlamova N., Reed E., Jiang X., Kallberg H., Pollak-Dorocic I., Israelsson L., Kessel C., Padyukov L., Holmdahl R., Alfredsson L., Klareskog L. Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile. Ann Rheum Dis 2013, 72:652-658.
23. Mahdi H., Fisher B.A., Kallberg H., Plant D., Malmstrom V., Ronnelid J., Charles P., Ding B., Alfredsson L., Padyukov L., Symmons D.P., Venables P.J., Klareskog L., Lundberg K. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet 2009, 41:1319-1324.
24. Amara K., Steen J., Murray F., Morbach H., Fernandez-Rodriguez B.M., Joshua V., Engstrom M., Snir O., Israelsson L., Catrina A.I., Wardemann H., Corti D., Meffre E., Klareskog L., Malmstrom V. Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J Exp Med 2013, 210:445-455.
25. Suwannalai P., Scherer H.U., ver der Woude D., Ioan-Facsinay A., Jol-van der Zijde C.M., van Tol M.J., Drijfhout A.W., Huizinga T.W., Toes R.E.M., Trouw L.A. Anti-citrullinated protein antibodies have a low avidiy compared with antibodies against recall antigens. Ann Rheum Dis 2011, 70:373-379.
26. Suwannalai P., van de Stadt L.A., Radner H., Steiner G., El-Gabalawy H.S., Jol-van der Zijde C.M., Toes R.E.M., Trouw L.A. Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum 2012, 64:1323-1328.
27. Ercan A., Cui J., Chatterton D.E.W., Deane K.D., Hazen M.M., Brintnell W., O'Donnell C.I., Derber L.A., Weinblatt M.E., Shadick N.A., Bell D.A., Cairns E., Solomon D.H., Holers V.M., Rudd P.M., Lee D.M. IgG galactosylation aberrancy precedes disease onset, correlates with disease activity and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum 2010, 62:2238-2248.
28. Scherer H.U., van der Woude D., Ioan-Facsinay A., el Bannoudi H., Trouw L.A., Wang J., Haupl T., Burmester G.-R., Deelder A.M., Huizinga T.W., Wuhrer M., Toes R.E.M. Glycan profiling of anti-citrullinaed protein antibodies isolated from human serum and synovial fluid. Arthritis Rheum 2010, 62:1620-1629.
29. Trouw L.A., Haisma E.M., Levarht E.W.N., van der Woude D., Ioan-Facsinay A., Daha M.R., Huizinga T.W., Toes R.E.M. Anti-cyclic peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways. Arthritis Rheum 2009, 60:1923-1931.
30. Laurent L., Clavel C., Lemaire O., Anquetil F., Cornillet M., Zabraniecki L., Nogueira L., Fournie B., Serre G., Sebbag M. Fc-gamma receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins. Ann Rheum Dis 2011, 70:1052-1059.
31. Willemze A., Trouw L.A., Toes R.E.M., Huizinga T.W.J. The influence of ACPA status and characteristics on the course of RA. Nat Rev Rheumatol 2012, 8:144-152.
32. Goldbach-Mansky R., Lee J., McCoy A., Hoxworth J., arboro C., Smolen J., Steiner G., Rosen A., Zhang C., Menard H.A., Zhou Z.J., Palosuo T., van Venrooij W.J., Wilder R.L., Klippel H.H., Schumacher H.R., El-Gabalawy H.S. Rheumatoid arthritis associated autoantibodies in patients wtih synovitis of recent onset. Arthritis Res Ther 2000, 2:236-243.
33. Demoruelle M.K., Deane K.D. Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significance. Curr Rheumatol Rep 2011, 13:421-430.
34. Shi J., Knevel R., Suwannalai P., van der Linden M.P.M., Janssen G.M., van Veelen P.A., Levarht N.E., van der Helm-van Mil A.H.M., Cerami A., Huizinga T.W., Toes R.E., Trouw L.A. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci USA 2011, 108:17372-17377.
35. Snir O., Rieck M., Gebe J.A., Yue B.B., Rawlings C.A., Nepom G.T., Malmstrom V., Buckner J.H. Identification and functional characterization of T cells reactive to citrullinated-vimentin in HLA-DRB1*0401 humanized mice and RA patients. Arthritis Rheum 2011, 63:2873-2883.
36. Feitsma A.L., van der Voort E.I., Franken K.L., el Bannoudi H., Elferink B.G., Drijfhout J.W., Huizinga T.W., de Vries R.R., Toes R.E., Ioan-Facsinay A. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive in patients with rheumatoid arthritis. Arthritis Rheum 2010, 62:117-125.
37. Law S.C., Street S., Yu C.H., Capini C., Ramnoruth S., Nel H.J., van Gorp E., Hyde C., Lau K., Pahau H., Purcell A.W., Thomas R. T-cell autoreactivity to citrullinated autoantigenic peptides in rheumatoid arthritis patients carrying HLA-DRB1 shared epitope alleles. Arthritis Res Ther 2012, 14:R118.
38. Deane K.D., Norris J.M., Holers V.M. Pre-clinical rheumatoid arthritis: identification, evaluation and future directions for investigation. Rheum Dis Clin North Am 2010, 236-241.
39. Gerlag D.M., Raza K., van Baarsen L.G.M., Brouwer E., Buckley C.D., Burmester G.R., Gabay C., Pope A.P., Cornelis F., Dahlqvist S.R., Emery P., Eyre S., Finckh A., Gay S., Hazes J.M.W., van der Helm-van Mil A.H.M., Huizinga T.W., Klareskog L., Kvien T.K., Lewis C., Machold K.P., Ronnelid J., van Schaardenburg D., Schett G., Smolen J.S., Thomas S., Worthington J., Tak P.P. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann Rheum Dis 2012, 71:638-641.
40. El-Gabalawy H.S., Robinson D.B., Smolik I., Hart D., Elias B., Wong K., Peschken C.A., Hitchon C.A., Li X., Bernstein C.N., Newkirk M.M., Fritzler M.J. Familial clustering of the serum cytokine profile in the relatives of rheumatoid arthritis patients. Arthritis Rheum 2012, 64:1720-1729.
41. Arlestig L., Mullazehi M., Kokkonen H., Rocklov J., Ronnelid J., Dahlqvist S.R. Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden. Ann Rheum Dis 2012, 71:825-829.
42. Barra L., Scinocca M., Saunders S., Bhayana R., Rohekar S., Racape M., Coles R., Cairns E., Bell D.A. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients. Arthritis Rheum 2013, 65:1439-1447.
43. Young K.A., Deane K.D., Derber L.A., Hughes-Austin J., Wagner C.A., Sokolove J., Weisman M.H., Buckner J.H., Mikuls T.R., O'Dell J.R., Keating R.M., Gregersen P.K., Robinson W.H., Holers V.M., Norris J.M. Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis. Arthritis Rheum 2013, 65:1995-2004.
44. Hughes-Austin J., Deane K.D., Derber L.A., Kolfenbach J.R., Zerbe G.O., Sokolov J., Lahey L.J., Weisman M.H., Buckner J.H., Mikuls T.R., O'Dell J.R., Keating R.M., Gregersen P.K., Robinson W.H., Holers V.M., Norris J.M. Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann Rheum Dis 2012, 72:901-907.
45. Brink M., Hansson M., Mathsson L., Jakobsson P.J., Holmdahl R., Hallmans G., Stenlund H., Ronnelid J., Klareskog L., Rantapaa Dahlqvist S. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to the development of rheumatoid arthritis. Arthritis Rheum 2013, 65:899-910.
46. Sokolove J., Bromberg R., Deane K.D., Lahey L.J., Derber L.A., Chandra P.E., Edison J.D., Gilliland W.R., Tibshirani R.J., Norris J.M., Holers V.M., Robinson W.H. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One 2012, 7:e35296.
47. Deane K.D., O'Donnell C.I., Hueber W., Majka D.S., Lazar A.A., Derber L.A., Gilliland W.R., Edison J.D., Norris J.M., Robinson W.H., Holers V.M. The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum 2010, 62:3161-3172.
48. Jorgensen K.T., Wiik a, Pedersen M., Hedegaard C.J., Gislefoss R.E., Kvien T.K., Wohlfahrt J., Bendtzen K.F.M. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis 2008, 67:860-866.
49. Karlson E.W., Chisnik L.B., Tworoger S.S., Li I.-M., Buring J.E., Shadick N.A., Manson J.E., Costenbader K.H. Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum 2009, 60:641-652.
50. Kokkonen H., Soderstrom I., Rocklov J., Hallmans G., Lejon K., Rantapaa Dahlqvist S. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 2010, 62:383-391.
51. Arbuckle M.R., McClain M.T., Rubertone M.V., Scofield R.H., Dennis G.J., James J.A., Harley J.B. Development of autoantibodies before the clinical onset of Systemic Lupus Erythematosus. NEJM 2003, 349:1526-1533.
52. Gottlieb P.A., Eisenbarth G.S. Diagnosis and treatment of pre-insulin dependent diabetes. Ann Rev Med 1998, 49:391-405.
53. Barton S.H., Murray J.A. Celiac disease and autoimmunity in the gut and elsewhere. Gastroenterol Clin North Am 2008, 37:411-428.
54. Burek C.L., Rose N.R. Autoimmune thyroiditis and ROS. Autoimmunity Rev 2008, 7:530-537.
55. van de Sande M.G.H., de Hair M.J.H., van der Leij C., Klarenbeek C.L., Bos W.H., Smith M.D., Maas M., de Vries N., van Schaardenburg D., Dijkmans B.A.C., Gerlag D.M., Tak P.-P. Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase. Ann Rheum Dis 2011, 70:772-777.
56. Hill J.A., Bell D.A., Brintnell W., Yue D., Wehrli B., Jevnikar A.M., Lee D.M., Hueber W., Robinson W.H., Cairns E. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice. J Exp Med 2008, 205:967-979.
57. Ho P.P., Lee L.Y., Zhao X., Tomooka B., Paniagua R.T., Sharpe O., Bencivenga R., Chandrasekaran A., Hueber W., Steinman L., Robinson W.H. Autoimmunity against fibrinogen mediates inflammatory arthritis in mice. J Immunol 2010, 184:379-390.
58. Kuhn K.A., Kulik L., Tomooka B., Braschler K.J., Arend W.P., Robinson W.H., Holers V.M. Antibodies to citrullinated proteins enhance tissue injury in experimental arthritis. J Clin Invest 2006, 116:961-973.
59. Lundberg K., Nijenhuis S., Vossenaar E.R., Palmblad K., van Venrooij W.J., Klareskog L., Zendman A.J., Harris H.E. Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity. Arthritis Res Ther 2005, 7:R458-R467.
60. Uysal H., Bockermann R., Nandakumar K.S., Sehnert B., Bajtner E., Engstrom A., Serre G., Burkhardt H., Thunnissen M.M.G.M., Holmdahl R. Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis. J Exp Med 2009, 206:449-462.
61. Thiele G.M., Duryee M.J., Dusad A., Hunter C.D., Lacy J.P., Anderson D.R., Wang D., O'Dell J.R., Mikuls T.R., Klassen L.W. Citrullinated mouse collagen administered to DBA/1J mice in the absence of adjuvant initiates arthritis. Int Immunopharmacol 2012, 13:424-431.
62. Harre U., Georgess D., Bang H., Bozec A., Axmann R., Ossipova E., Jakobsson P.J., Baum W., Nimmerjahn F., Szarka E., Sarmay G., Krumbholz G., Neumann E., Toes R.E., Scherer H.U., Catrina A., Klareskog L., Jurdic P., Schett G. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 2012, 122:1791-1802.
63. Kokkonen H., Mullazehi M., Berglin E., Hallmans G., Wadell G., Ronnelid J., Rantapaa Dahlqvist S. Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthritis Res Ther 2011, 13:R13.
64. Nielen M.M.J., van Schaardenburg D., Reesink H.W., van de Stadt R.J., van der Horst-Bruinsma I.E., de Koning M.H.M.T., Habibuw M.R., Vandenbroucke J.P., Dijkmans B.A.C. Specific autoantibodies precede the symptoms of rheumatoid arthritis. Arthritis Rheum 2004, 50:380-386.
65. Rantapaa Dahlqvist S., de Jong B.A.W., Hallmans G., Wadell G., Sundin U., vanVenrooij W.J. Antibodies against citrullinated peptides (CCP) predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48:2701-2705.
66. Smit M.D., Westra J., Vissink A., Doombos-van der Meer B., Brouwer E., van Winkelhoff A.J. Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study. Arthritis Res Ther 2012, 14:R222.
67. Wegner N., Wait R., Sroka A., Eick S., Nguyen K.A., Lundberg K., Kinloch A., Culshaw S., Potempa J., Venables P.J. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and a-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum 2010, 62:2662-2672.
68. Mikuls T.R., Thiele G.M., Deane K.D., Payne J.B., O'Dell J.R., Yu F., Sayles H., Weisman M.H., Gregersen P.K., Buckner J.H., Keating R.M., Derber L.A., Robinson W.H., Holers V.M., Norris J.M. Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum 2012, 64:3522-3530.
69. Scher J.U., Ubeda C., Equinda M., Khanin R., Buischi Y., Viale A., Lipuma L., Attur M., Pillinger M.H., Weissman G., Littman D.R., Pamer E.G., Bretz W.A., Abramson S.B. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum 2012, 64:3083-3094.
70. Metafratzi Z.M., Georgiadis A.N., Ioannidou C.V., Alamanos Y., Vassiliou M.P., Zikou A.K., Raptis G., Drosos A.A., Efremidis S.C. Pulmonary involvement in patients with early rheumatoid arthritis. Scand J Rheumatol 2007, 38:338-344.
71. Demoruelle M.K., Weisman M.H., Simonian P.L., Lynch D.A., Sachs P.B., Pedraza I.F., Harrington A.R., Kolfenbach J.R., Striebich C.C., Pham Q.N., Strickland C.D., Petersen B.D., Parish M.C., Derber L.A., Holers V.M., Norris J.M., Deane K.D. Airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?. Arthritis Rheum 2012, 64:1756-1761.
72. Willis V.C., Demoruelle M.K., Derber L.A., Chartier-Logan C.J., Parish M.C., Pedraza I.F., Weisman M.H., Norris J.M., Holers V.M., Deane K.D. Sputa autoantibodies in patients with established rheumatoid arthritis and subjects at-risk for future clinically apparent disease. Arthritis Rheum 2013, 65:2545-2554.
73. Rangel-Moreno J., Hartson L., Navarro C., Gaxiola M., Selman M., Randall T.D. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006, 116:3183-3194.
74. Wu H.J., Ivanov Il, Darce J., Hattori K.S.T., Umesaki Y., Littman D.R., Benoist C., Mathis D. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.
75. Vaahtovuo J., Munukka E., Korkeamaki M., Toivanen P. Fecal microbiota in early rheumatoid arthritis. J Rheumatol 2008, 35:1500-1505.
76. de Hair M.J.H., Zijlstra I.A.J., Boumans M.J.H., van de Sande M.G.H., Mass M., Gerlag D.M., Tak P.P. Hunting for the pathogenesis of rheumatoid arthritis: core-needle biopsy of inguinal lymph nodes as a new research tool. Ann Rheum Dis 2012, 71:1191-1192.
77. Bekeredjian-Ding I., Jego G. Toll-like receptors-sentries in the B-cell response. Immunology 2009, 128:311-323.
78. Seong S.Y., Matzinger P. Hydrophobocity: an ancient damage-associated molecular pattern that initiates innae immune responses. Nat Rev Immunol 2004, 4:469-478.
79. Khandpur R., Carmona-Rivera C., Vivekanandan-Giri A., Gizinski A.M., Yalavarthi S., Knight J.S., Friday S., Li S., Patel R.M., Subramanian V., Thompson P., Chen P., Fox D.A., Pennathur S., Kaplan M.J. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Trans Med 2013, 5:178ra40. 10.1126/scitranslmed.3005580.
80. Arend W.P., Firestein G.S. Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nat Rev Rheumatol 2012, 8:573-576.
81. Zhao X., Okeke N.L., Sharpe O., Batliwalla F.M., Lee A.T., Ho P.P., Tomooka B.H., Gregersen P.K., Robinson W.H. Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis. Arthritis Res Ther 2008, 10:R94.
82. Sokolove J., Zhao X., Chandra P.E., Robinson W.H. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fc-gamme receptor. Arthritis Rheum 2011, 63:53-62.
83. Cordova K.N., Willis V.C., Haskins K., Holers V.M. A citrullinated fibrinogen-specific T cell line enhances autoimmune arthritis in a mouse model of rheumatoid arthritis. J Immunol 2013, 190:1457-1465.
84. Ytterberg A.J., Ossipova E., Rutishauser D., Hensvold A., Eklund A., Skold M., Grunewald J., Lundberg K., Malmstrom V., Jakobsson P.J., Zubarev R., Klareskog L., Catrina A. Identification of shared citrullinated immunological targets in the lungs and joints of patients with rheumatoid arthritis. Ann Rheum Dis 2012, European Workshop for Rheumatology Research:A19.
85. Demoruelle M.K., Deane K.D. Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis. Curr Rheumatol Rep 2012, 14:472-480.
86. Klareskog L., Gregersen P.K., Huizinga T.W. Prevention of autoimmune rheumatic disease: state of the art and future perspectives. Ann Rheum Dis 2010, 69:2062-2069.